$146.43
-0.39[-0.27%]
At close: Apr 25
$146.43
0[0.00%]
After Hours: 7:50PM EDT
Johnson & Johnson reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Johnson & Johnson using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
07/18/2024 | AM | JNJ | Q2 | $2.80 | — | — | — | $25.53B | — | — | — | Get Alert |
04/16/2024 | AM | JNJ | Q1 | $2.41 | $2.64 | $2.71 | 2.65% | $20.89B | $21.41B | $21.38B | -0.13% | Get Alert |
01/23/2024 | AM | JNJ | Q4 | $2.05 | $2.28 | $2.29 | 0.44% | $23.71B | $20.99B | $21.39B | 1.93% | Get Alert |
10/17/2023 | AM | JNJ | Q3 | $2.23 | $2.51 | $2.66 | 5.98% | $20.00B | $21.04B | $21.35B | 1.48% | Get Alert |
07/20/2023 | AM | JNJ | Q2 | $2.59 | $2.62 | $2.80 | 6.87% | $24.02B | $24.63B | $25.53B | 3.65% | Get Alert |
04/18/2023 | AM | JNJ | Q1 | $2.67 | $2.51 | $2.68 | 6.77% | $23.43B | $23.67B | $24.75B | 4.55% | Get Alert |
01/24/2023 | AM | JNJ | Q4 | $2.13 | $2.23 | $2.35 | 5.38% | $24.80B | $23.94B | $23.71B | -0.98% | Get Alert |
10/18/2022 | AM | JNJ | Q3 | $2.60 | $2.52 | $2.55 | 1.19% | $23.34B | $23.47B | $23.79B | 1.37% | Get Alert |
07/19/2022 | AM | JNJ | Q2 | $2.48 | $2.57 | $2.59 | 0.78% | $23.32B | $23.81B | $24.02B | 0.88% | Get Alert |
04/19/2022 | AM | JNJ | Q1 | $2.59 | $2.61 | $2.67 | 2.30% | $22.32B | $23.67B | $23.43B | -1.03% | Get Alert |
01/25/2022 | AM | JNJ | Q4 | $1.86 | $2.12 | $2.13 | 0.47% | $22.48B | $25.29B | $24.80B | -1.92% | Get Alert |
10/19/2021 | AM | JNJ | Q3 | $2.20 | $2.36 | $2.60 | 10.17% | $21.08B | $23.74B | $23.34B | -1.69% | Get Alert |
07/21/2021 | AM | JNJ | Q2 | $1.67 | $2.27 | $2.48 | 9.25% | $18.34B | $22.19B | $23.32B | 5.10% | Get Alert |
04/20/2021 | AM | JNJ | Q1 | $2.30 | $2.34 | $2.59 | 10.68% | $20.69B | $22.01B | $22.32B | 1.41% | Get Alert |
01/26/2021 | AM | JNJ | Q4 | $1.88 | $1.82 | $1.86 | 2.20% | $20.75B | $21.67B | $22.48B | 3.71% | Get Alert |
10/13/2020 | AM | JNJ | Q3 | $2.12 | $1.98 | $2.20 | 11.11% | $20.73B | $20.20B | $21.08B | 4.37% | Get Alert |
07/16/2020 | AM | JNJ | Q2 | $2.58 | $1.48 | $1.67 | 12.84% | $20.56B | $17.50B | $18.34B | 4.78% | Get Alert |
04/14/2020 | AM | JNJ | Q1 | $2.10 | $1.99 | $2.30 | 15.58% | $20.02B | $19.44B | $20.69B | 6.44% | Get Alert |
01/22/2020 | AM | JNJ | Q4 | $1.97 | $1.87 | $1.88 | 0.53% | $20.39B | $20.78B | $20.75B | -0.16% | Get Alert |
Johnson & Johnson (JNJ) is scheduled to report earnings on July 18, 2024. The last reported earnings were for reported on April 16, 2024 for Q1.
The Actual EPS was $2.71, which beat the estimate of $2.64.
The Actual Revenue was $21.4B, which missed the estimate of $21.4B.
Browse earnings estimates, EPS, and revenue on all stocks.